Is meropenem effective for treating a scrotal abscess with a nearby prosthetic ureteral (urinary) stent?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Meropenem for Scrotal Abscess with Nearby Prosthetic Ureteral Stent

Meropenem is an appropriate and effective antibiotic choice for treating a scrotal abscess with a nearby prosthetic ureteral stent, as it provides broad-spectrum coverage against likely pathogens including Gram-negative bacteria, anaerobes, and many Gram-positive organisms that may be involved in this complex infection. 1, 2

Rationale for Using Meropenem

Meropenem is indicated for the following reasons:

  1. Broad-spectrum coverage: Scrotal abscesses with nearby prosthetic devices represent complicated infections that may involve multiple pathogens:

    • Gram-negative bacteria (including Pseudomonas and ESBL-producing Enterobacteriaceae)
    • Anaerobes
    • Gram-positive organisms
  2. FDA-approved indications: While scrotal abscess is not specifically listed in the FDA label, meropenem is approved for:

    • Complicated skin and skin structure infections
    • Complicated intra-abdominal infections 2
  3. Penetration into infected tissues: Meropenem achieves good tissue penetration in genitourinary structures 3

  4. Prosthetic device consideration: The presence of a ureteral stent increases the risk of biofilm formation and requires an agent with good penetration and activity against potential uropathogens 1

Dosing Recommendations

For adults with normal renal function:

  • Standard dose: 1 gram IV every 8 hours 2
  • Administration: Intravenous infusion over 15-30 minutes or as an IV bolus over 3-5 minutes 2
  • Duration: 10-14 days for complicated infections involving prosthetic devices 1

Adjust dosing for renal impairment:

  • CrCl >50 mL/min: Standard dose every 8 hours
  • CrCl 26-50 mL/min: Standard dose every 12 hours
  • CrCl 10-25 mL/min: Half recommended dose every 12 hours
  • CrCl <10 mL/min: Half recommended dose every 24 hours 2

Surgical Management Considerations

Antibiotic therapy alone is insufficient. Surgical source control is essential:

  • Incision and drainage of the abscess
  • Debridement of necrotic tissue
  • Collection of specimens for culture and sensitivity testing 1

The decision regarding the ureteral stent should be based on:

  • Extent of infection
  • Duration of stent placement
  • Clinical condition of the patient
  • Consider removal if the stent appears to be the source of infection 1

Potential Alternative Regimens

If meropenem is unavailable or contraindicated, consider:

  1. Piperacillin-tazobactam: 4.5g IV every 6-8 hours 1
  2. Ceftazidime-avibactam or ceftolozane-tazobactam with metronidazole (for carbapenem-sparing approaches) 1
  3. Imipenem-cilastatin or doripenem: Alternative carbapenems with similar spectrum 1

Important Clinical Considerations

  1. Obtain cultures before starting antibiotics: This is crucial for targeted therapy once results are available 4

  2. Monitor for treatment response: Clinical improvement should be seen within 48-72 hours; if not, reassess the treatment plan 4

  3. Antibiotic stewardship: While meropenem is appropriate for this serious infection, be mindful of the potential for developing resistance 1

  4. Duration of therapy: Extended treatment (10-14 days) is typically needed for infections involving prosthetic devices 4

  5. Underlying conditions: Evaluate for conditions that may complicate treatment or require additional management:

    • History of urethral stricture (may be associated with squamous cell carcinoma) 5
    • Diabetes (higher risk of complications) 4

Pitfalls to Avoid

  1. Inadequate source control: Antibiotics alone will not resolve an abscess without proper drainage 1

  2. Overlooking the possibility of malignancy: In patients with recurrent scrotal abscesses or urethral strictures, consider biopsy to rule out squamous cell carcinoma 5

  3. Failure to adjust for renal function: Meropenem requires dose adjustment in renal impairment 2, 6

  4. Premature discontinuation of therapy: Due to the presence of the prosthetic device, shortened courses of antibiotics may lead to treatment failure 4

  5. Overlooking polymicrobial nature: Scrotal abscesses, especially with nearby foreign bodies, often involve multiple pathogens 1

Meropenem represents an excellent choice for this complex infection scenario, providing appropriate coverage while surgical source control is achieved.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Urinary Tract Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.